Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Search tool

Displaying 1 - 20 of 57

News

EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids

19.12.2022

On 16 December, the EMCDDA held the first ‘Technical expert meeting on hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSCs)’ as part of its ongoing work to support EU and national preparedness and response to emerging NPS risks. Hexahydrocannabinol is the first semi-synthetic

News

EMCDDA participates in Latin American regional meeting on early warning systems

09.12.2022

This week, the EMCDDA participated in a meeting ‘Early warning systems in response to opioids and new psychoactive substances’, organised by the Inter-Ame

News

No laughing matter - new report shows rise in recreational use of nitrous oxide

21.11.2022

A rise in the supply and recreational use of nitrous oxide (‘laughing gas’) is the focus of a new report out today from the EU drugs agency (EMCDDA).

News

25 years of monitoring and responding to new drugs in Europe — update published today

14.06.2022

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary.

News

Drug supply and use bounce back after COVID-19 disruption

14.06.2022

The rapid bounce back of drug supply and use following COVID-19 disruption is among the issues highlighted today by the EU drugs agency (EMCDDA) as it launches its European Drug Report 2022: Trends and Developments (

News

25 years of early warning and response to new psychoactive substances in Europe

07.06.2022

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary.

News

Coming soon: latest analyses of Europe’s cocaine and methamphetamine markets

29.04.2022

Drug trafficking is a highly profitable commercial activity and remains a core business for organised crime groups across Europe today.

News

European Commission adopts measures to control two harmful new drugs amidst health concerns and surge in supply

18.03.2022

Today, the European Commission has adopted measures to control two harmful new psychoactive substances (NPS) across the EU (1). The substances in question —

News

New report highlights public health and social risks posed by synthetic cannabinoids in Europe

09.09.2021

Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA).

News

New report highlights public health risks and increasing availability of ‘designer benzodiazepines’ in Europe

09.06.2021

New benzodiazepines, which are not controlled by international drug laws, come under the spotlight today in a new report released by the EU drugs agency (EMCDDA) (1).

News

European Commission proposes to control two harmful new psychoactive substances

12.03.2021

Today, the European Commission has proposed to control two harmful new psychoactive substances (NPS) across the European Union. The substances in question — MDMB-4en-PINACA and 4F-MDMB-BICA — are both synthetic cannabinoids, which have been raising health concerns in Europe (1).

News

COVID-19 disruption and a strong drug market bring new threats to health and security in Europe

22.09.2020

High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the EU drugs agency (EMCDDA) in its European Drug Report 2020: Trends and Developments (1).

News

New report provides window onto EU drug market changes during COVID-19

29.05.2020

What effect is COVID-19 having on the largest criminal market in the EU?

News

New report highlights wide-ranging impacts of EU drug markets on health and security

26.11.2019

Europeans are spending at least EUR 30 billion on drugs each year at retail level, making the drug market a major source of income for organised crime groups in the European Union.

News

Cocaine seizures at record levels in a competitive drug market

06.06.2019

Europe is seeing signs of an increase in cocaine availability, with seizures of the drug at record levels.

News

New legislation, bringing faster response to new drugs, applies from today

23.11.2018

Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) will be significantly strengthened, thanks to new legislation applying from today (1).

News

Two new synthetic opioids to be placed under control across the EU

28.09.2018

Today, the European Union has decided to subject two new synthetic opioids to control measures across the 28 Member States.

News

EMCDDA: resurgence of cocaine in a dynamic drug market

07.06.2018

Evidence of increased cocaine availability is highlighted by the EMCDDA today in its European Drug Report 2018: Trends and Developments released in Brussels. The development occurs in the context of a dynamic drug market which is able to adapt rapidly in response to drug control measures.

News

EMCDDA publishes latest insights into NPS in Europe

07.06.2018

In a new update from the EU Early Warning System (EWS) on new psychoactive substances (NPS) (1), the EMCDDA releases today its latest insights in this area entitled Fentanils and synthetic c

News

EMCDDA Director addresses Congress of the European Association of Poisons Centres and Clinical Toxicologists

24.05.2018

EMCDDA Director Alexis Goosdeel will today address the 38th Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) taking place on 23 and 24 May in Bucharest.
Loading